C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -83,892 | -68,234 | -43,551 | -20,971 | -66,335 |
| Depreciation Amortization | 4,090 | 2,741 | 1,673 | 735 | 1,931 |
| Accounts receivable | -1,232 | -361 | -1,729 | 828 | 139 |
| Accounts payable and accrued liabilities | -1,179 | -1,939 | -1,338 | -1,965 | 467 |
| Other Working Capital | -30,090 | -11,940 | -10,778 | -8,863 | -13,177 |
| Other Operating Activity | 25,338 | 18,439 | 12,787 | 5,302 | 9,726 |
| Operating Cash Flow | $-86,965 | $-61,294 | $-42,936 | $-24,934 | $-67,249 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -188,059 | -392,324 | -237,622 | -176,303 | -189,855 |
| PPE Investments | -1,277 | -1,168 | -1,168 | -421 | -650 |
| Sale Of Investment | N/A | 263,569 | 209,494 | 114,994 | N/A |
| Investing Cash Flow | $-189,336 | $-129,923 | $-29,296 | $-61,730 | $-190,505 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 11,973 |
| Common Stock Issued | 171,795 | 171,043 | 170,639 | 166 | 195,961 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -921 |
| Other Financing Activity | -395 | -109 | -289 | -317 | 141,919 |
| Financing Cash Flow | $171,400 | $170,934 | $170,350 | $-151 | $348,932 |
| Beginning Cash Position | 184,304 | 184,304 | 184,304 | 184,304 | 93,126 |
| End Cash Position | 79,403 | 164,021 | 282,422 | 97,489 | 184,304 |
| Net Cash Flow | $-104,901 | $-20,283 | $98,118 | $-86,815 | $91,178 |
| Free Cash Flow | |||||
| Operating Cash Flow | -86,965 | -61,294 | -42,936 | -24,934 | -67,249 |
| Capital Expenditure | -1,277 | -1,168 | -1,168 | -421 | -650 |
| Free Cash Flow | -88,242 | -62,462 | -44,104 | -25,355 | -67,899 |